Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FWUXJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,829
Award facts
- Contract value 100% obligated
- $20,829.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on September 26, 2025, for the supply of Nexplanon 68 mg implants, a reversible contraceptive device. The contract is valued at $20,829.00 with firm fixed-price terms and an ultimate completion date of October 20, 2025. This delivery order represents a specific product request under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and extending through November 2026. The award was made without a set-aside designation, allowing the woman-owned small business to compete directly in the federal marketplace. Performance will occur at DMS Pharmaceutical Group's facility in Park Ridge, Illinois.
DMS Pharmaceutical Group Inc. is an established woman-owned small business pharmaceutical wholesaler that has served as a critical supplier to the Defense Logistics Agency since its SAM.gov registration in 2001. The company's federal contracting portfolio demonstrates extensive experience distributing a comprehensive range of pharmaceutical products to Department of Defense healthcare facilities, including prescription medications, biologics, vaccines, and specialty medications. This delivery order for Nexplanon implants aligns with the company's core capabilities in supplying contraceptive devices and other medical consumables to military health facilities nationwide, reinforcing its strategic role in supporting federal pharmaceutical supply chain requirements.
Quick answers
Who was awarded contract SPE2DB25FWUXJ?
SPE2DB25FWUXJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FWUXJ worth?
The government has obligated $20,829 on SPE2DB25FWUXJ.
Is contract SPE2DB25FWUXJ an order under another contract?
Yes. SPE2DB25FWUXJ is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUXJ competed?
The extent of competition for SPE2DB25FWUXJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award